Maybe it is time for Medmira to think "outside the box"
and explore other alternatives such as:
1) licensing out their products and intelectual assets.
2) Sell parts of the company to a Chinese company and buy back shares.
3) Put itself up for sale or go private.
4) Merge with another company by swapping stocks.
5) Hire Chinese and British salespeople with medical background and connections.